Deal facts
- Buyer
- WATERS
- Target
- BD (BIOSCIENCES AND DIAGNOSTIC SOLUTIONS BUSINESSES)
- Deal value
- Not disclosed
- Announced
- 29 October 2025
- Status
- In review
- Sector
- Healthcare
- Country
- Not stated
- Consideration
- Not stated
Sources
WATERS has agreed to acquire the BIOSCIENCES AND DIAGNOSTIC SOLUTIONS BUSINESSES of BD in a strategic acquisition announced on 29 October 2025. The transaction involves the purchase of specific business units within the target organisation, operating within the NaceV2Sector_C_32.50 classification. No financial consideration or deal value was disclosed in the available information regarding this transaction. The buyer intends to integrate these assets into its existing portfolio to expand its capabilities in the relevant sector.
The deal remains subject to regulatory approval and other customary closing conditions before completion. As of the latest update, the transaction status is recorded as in review. No completion date has been confirmed at this stage. The parties are currently proceeding through the necessary regulatory processes required to finalise the agreement. Further details regarding the specific terms of the arrangement have not been made public.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CMA invitation to comment
WATERS to acquire BD (BIOSCIENCES AND DIAGNOSTIC SOLUTIONS BUSINESSES)
WATERS to acquire BD (BIOSCIENCES AND DIAGNOSTIC SOLUTIONS BUSINESSES)
EU DG COMP
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Dolby Medical Home Respiratory Care Limited (Vivisol) to acquire Air Liquide Healthcare Limited’s home oxygen services business
Dolby Medical Home Respiratory Care Limited, trading as Vivisol, has agreed to acquire the home oxygen services business of Air Liquide Healthcare Limited in a strategic…
- Buyer
- Dolby Medical Home Respiratory Care Limited (Vivisol)
- Target
- Air Liquide Healthcare Limited’s home oxygen services business
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
RSLGH, LLC to acquire RYTHM, Inc.
RSLGH, LLC has agreed to acquire RYTHM, Inc., a healthcare company based in the United States, in a strategic acquisition valued at $109.5 million. The transaction invol…
- Buyer
- RSLGH, LLC
- Target
- RYTHM, Inc.
- Deal value
- USD 109,500,000
- Deal type
- strategic acquisition
Ensysce Biosciences, Inc. to acquire Cy Biopharma, Inc.
Ensysce Biosciences, Inc. has agreed to acquire Cy Biopharma, Inc. in a strategic acquisition within the healthcare sector. The transaction was announced on 5 August 202…
- Buyer
- Ensysce Biosciences, Inc.
- Target
- Cy Biopharma, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Profusa, Inc. to acquire G3 Vision Labs Inc.
Profusa, Inc. has agreed to acquire G3 Vision Labs Inc. in a strategic acquisition within the healthcare sector. The transaction involves the exchange of shares as the p…
- Buyer
- Profusa, Inc.
- Target
- G3 Vision Labs Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
WATERS
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive